Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

The effects of canola and olive oils on insulin resistance, inflammation and oxidative stress in women with type 2 diabetes: a randomized and controlled trial.

Atefi M, Pishdad GR, Faghih S.

J Diabetes Metab Disord. 2018 May 23;17(2):85-91. doi: 10.1007/s40200-018-0343-9. eCollection 2018 Dec.

2.

Evaluation of Blood Parameters Alteration Following Low-dose Radiation Induced by Myocardial Perfusion Imaging.

Alavi MS, Okhovat MA, Atefi M, Khajeh Rahimi F, Mortazavi S, Ebadi F.

J Biomed Phys Eng. 2018 Jun 1;8(2):179-184. eCollection 2018 Jun.

3.

Multi-stage Differentiation Defines Melanoma Subtypes with Differential Vulnerability to Drug-Induced Iron-Dependent Oxidative Stress.

Tsoi J, Robert L, Paraiso K, Galvan C, Sheu KM, Lay J, Wong DJL, Atefi M, Shirazi R, Wang X, Braas D, Grasso CS, Palaskas N, Ribas A, Graeber TG.

Cancer Cell. 2018 May 14;33(5):890-904.e5. doi: 10.1016/j.ccell.2018.03.017. Epub 2018 Apr 12.

4.

Proinflammatory Cytokines IL-6 and TNF-α Increased Telomerase Activity through NF-κB/STAT1/STAT3 Activation, and Withaferin A Inhibited the Signaling in Colorectal Cancer Cells.

Chung SS, Wu Y, Okobi Q, Adekoya D, Atefi M, Clarke O, Dutta P, Vadgama JV.

Mediators Inflamm. 2017;2017:5958429. doi: 10.1155/2017/5958429. Epub 2017 Jun 6.

5.

Using ß-cyclodextrin and Arabic Gum as Wall Materials for Encapsulation of Saffron Essential Oil.

Atefi M, Nayebzadeh K, Mohammadi A, Mortazavian AM.

Iran J Pharm Res. 2017 Winter;16(1):93-102.

6.

Greater adherence to the dietary approaches to stop hypertension (DASH) dietary pattern is associated with lower blood pressure in healthy Iranian primary school children.

Najafi A, Faghih S, Hojhabrimanesh A, Najafi M, Tangestani H, Atefi M, Teymouri M, Salehi M, Kamali M, Amanat S, Akhlaghi M.

Eur J Nutr. 2018 Jun;57(4):1449-1458. doi: 10.1007/s00394-017-1423-1. Epub 2017 Mar 21.

PMID:
28321547
7.

Aberrant Phosphorylation of SMAD4 Thr277-Mediated USP9x-SMAD4 Interaction by Free Fatty Acids Promotes Breast Cancer Metastasis.

Wu Y, Yu X, Yi X, Wu K, Dwabe S, Atefi M, Elshimali Y, Kemp KT 2nd, Bhat K, Haro J, Sarkissyan M, Vadgama JV.

Cancer Res. 2017 Mar 15;77(6):1383-1394. doi: 10.1158/0008-5472.CAN-16-2012. Epub 2017 Jan 23.

8.

Lactate, a Neglected Factor for Diabetes and Cancer Interaction.

Wu Y, Dong Y, Atefi M, Liu Y, Elshimali Y, Vadgama JV.

Mediators Inflamm. 2016;2016:6456018. doi: 10.1155/2016/6456018. Epub 2016 Dec 18. Review.

9.

Look Different: Effect of Radiation Hormesis on the Survival Rate of Immunosuppressed Mice.

Alavi M, Taeb S, Okhovat MA, Atefi M, Negahdari F.

J Biomed Phys Eng. 2016 Sep 1;6(3):139-146. eCollection 2016 Sep.

10.

JUN dependency in distinct early and late BRAF inhibition adaptation states of melanoma.

Titz B, Lomova A, Le A, Hugo W, Kong X, Ten Hoeve J, Friedman M, Shi H, Moriceau G, Song C, Hong A, Atefi M, Li R, Komisopoulou E, Ribas A, Lo RS, Graeber TG.

Cell Discov. 2016 Sep 6;2:16028. doi: 10.1038/celldisc.2016.28. eCollection 2016.

11.

Cutaneous wound healing through paradoxical MAPK activation by BRAF inhibitors.

Escuin-Ordinas H, Li S, Xie MW, Sun L, Hugo W, Huang RR, Jiao J, de-Faria FM, Realegeno S, Krystofinski P, Azhdam A, Komenan SM, Atefi M, Comin-Anduix B, Pellegrini M, Cochran AJ, Modlin RL, Herschman HR, Lo RS, McBride WH, Segura T, Ribas A.

Nat Commun. 2016 Aug 1;7:12348. doi: 10.1038/ncomms12348.

12.

CRAF R391W is a melanoma driver oncogene.

Atefi M, Titz B, Tsoi J, Avramis E, Le A, Ng C, Lomova A, Lassen A, Friedman M, Chmielowski B, Ribas A, Graeber TG.

Sci Rep. 2016 Jun 8;6:27454. doi: 10.1038/srep27454.

13.

An update on radiation absorbed dose to patients from diagnostic nuclear medicine procedures in Tehran: A study on four academic centers.

Motazedian M, Tabeie F, Vatankhah P, Shafiei B, Amoui M, Atefi M, Ansari M, Asli IN.

Indian J Nucl Med. 2016 Apr-Jun;31(2):119-22. doi: 10.4103/0972-3919.178262.

14.

A Western dietary pattern is associated with higher blood pressure in Iranian adolescents.

Hojhabrimanesh A, Akhlaghi M, Rahmani E, Amanat S, Atefi M, Najafi M, Hashemzadeh M, Salehi S, Faghih S.

Eur J Nutr. 2017 Feb;56(1):399-408. doi: 10.1007/s00394-015-1090-z. Epub 2015 Nov 3.

PMID:
26534856
15.

Erratum to: Antitumor activity of the ERK inhibitor SCH722984 against BRAF mutant, NRAS mutant and wild-type melanoma.

Wong DJ, Robert L, Atefi MS, Lassen A, Avarappatt G, Cerniglia M, Avramis E, Tsoi J, Foulad D, Graeber TG, Comin-Anduix B, Samatar A, Lo RS, Ribas A.

Mol Cancer. 2015 Jul 2;14:128. doi: 10.1186/s12943-015-0393-2. No abstract available.

16.

Combination of pan-RAF and MEK inhibitors in NRAS mutant melanoma.

Atefi M, Titz B, Avramis E, Ng C, Wong DJ, Lassen A, Cerniglia M, Escuin-Ordinas H, Foulad D, Comin-Anduix B, Graeber TG, Ribas A.

Mol Cancer. 2015 Feb 3;14:27. doi: 10.1186/s12943-015-0293-5.

17.

Antitumor activity of the ERK inhibitor SCH772984 [corrected] against BRAF mutant, NRAS mutant and wild-type melanoma.

Wong DJ, Robert L, Atefi MS, Lassen A, Avarappatt G, Cerniglia M, Avramis E, Tsoi J, Foulad D, Graeber TG, Comin-Anduix B, Samatar A, Lo RS, Ribas A.

Mol Cancer. 2014 Aug 20;13:194. doi: 10.1186/1476-4598-13-194. Erratum in: Mol Cancer. 2015;14:128.

18.

The effect of a new impregnated gauze containing bentonite and halloysite minerals on blood coagulation and wound healing.

Alavi M, Totonchi A, Okhovat MA, Motazedian M, Rezaei P, Atefi M.

Blood Coagul Fibrinolysis. 2014 Dec;25(8):856-9. doi: 10.1097/MBC.0000000000000172.

PMID:
25004023
19.

Effects of MAPK and PI3K pathways on PD-L1 expression in melanoma.

Atefi M, Avramis E, Lassen A, Wong DJ, Robert L, Foulad D, Cerniglia M, Titz B, Chodon T, Graeber TG, Comin-Anduix B, Ribas A.

Clin Cancer Res. 2014 Jul 1;20(13):3446-57. doi: 10.1158/1078-0432.CCR-13-2797. Epub 2014 May 8.

20.

Exposure to a histone deacetylase inhibitor has detrimental effects on human lymphocyte viability and function.

Wong DJ, Rao A, Avramis E, Matsunaga DR, Komatsubara KM, Atefi MS, Escuin-Ordinas H, Chodon T, Koya RC, Ribas A, Comin-Anduix B.

Cancer Immunol Res. 2014 May;2(5):459-68. doi: 10.1158/2326-6066.CIR-13-0188. Epub 2014 Jan 30.

21.

Effects of AKT inhibitor therapy in response and resistance to BRAF inhibition in melanoma.

Lassen A, Atefi M, Robert L, Wong DJ, Cerniglia M, Comin-Anduix B, Ribas A.

Mol Cancer. 2014 Apr 16;13:83. doi: 10.1186/1476-4598-13-83.

22.

COX-2 inhibition prevents the appearance of cutaneous squamous cell carcinomas accelerated by BRAF inhibitors.

Escuin-Ordinas H, Atefi M, Fu Y, Cass A, Ng C, Huang RR, Yashar S, Comin-Anduix B, Avramis E, Cochran AJ, Marais R, Lo RS, Graeber TG, Herschman HR, Ribas A.

Mol Oncol. 2014 Mar;8(2):250-60. doi: 10.1016/j.molonc.2013.11.005. Epub 2013 Dec 1.

23.

Evaluation of chemical and microbiological quality in 21 brands of Iranian bottled drinking waters in 2012: a comparison study on label and real contents.

Moazeni M, Atefi M, Ebrahimi A, Razmjoo P, Vahid Dastjerdi M.

J Environ Public Health. 2013;2013:469590. doi: 10.1155/2013/469590. Epub 2013 Apr 15.

24.

Scientific publications on medical ethics in thomson reuters database, 1990-2010.

Morovati M, Ejraei A, Hadi Z, Atefi M, Morovati MJ.

Iran J Med Sci. 2012 Dec;37(4):277-8. No abstract available.

25.

Dendritic cell-based immunotherapy in prevention and treatment of renal cell carcinoma: efficacy, safety, and activity of Ad-GM·CAIX in immunocompetent mouse models.

Birkhäuser FD, Koya RC, Neufeld C, Rampersaud EN, Lu X, Micewicz ED, Chodon T, Atefi M, Kroeger N, Chandramouli GV, Li G, Said JW, McBride WH, Kabbinavar FF, Ribas A, Pantuck AJ, Belldegrun AS, Riss J.

J Immunother. 2013 Feb;36(2):102-11. doi: 10.1097/CJI.0b013e31827bec97.

26.

CoolClot, a novel hemostatic agent for controlling life-threatening arterial bleeding.

Mortazavi S, Tavasoli A, Atefi M, Tanide N, Radpey N, Roshan-Shomal P, Moradi H, Taeb S.

World J Emerg Med. 2013;4(2):123-7. doi: 10.5847/wjem.j.1920-8642.2013.02.007.

27.

PET imaging to non-invasively study immune activation leading to antitumor responses with a 4-1BB agonistic antibody.

Escuin-Ordinas H, Elliott MW, Atefi M, Lee M, Ng C, Wei L, Comin-Anduix B, Montecino-Rodriguez E, Avramis E, Radu C, Sharp LL, Ribas A.

J Immunother Cancer. 2013 Aug 27;1:14. doi: 10.1186/2051-1426-1-14. eCollection 2013.

28.

BRAF(L597) mutations in melanoma are associated with sensitivity to MEK inhibitors.

Dahlman KB, Xia J, Hutchinson K, Ng C, Hucks D, Jia P, Atefi M, Su Z, Branch S, Lyle PL, Hicks DJ, Bozon V, Glaspy JA, Rosen N, Solit DB, Netterville JL, Vnencak-Jones CL, Sosman JA, Ribas A, Zhao Z, Pao W.

Cancer Discov. 2012 Sep;2(9):791-7. Epub 2012 Jul 13.

29.

Antitumor effects of the investigational selective MEK inhibitor TAK733 against cutaneous and uveal melanoma cell lines.

von Euw E, Atefi M, Attar N, Chu C, Zachariah S, Burgess BL, Mok S, Ng C, Wong DJ, Chmielowski B, Lichter DI, Koya RC, McCannel TA, Izmailova E, Ribas A.

Mol Cancer. 2012 Apr 19;11:22.

30.

Reversing melanoma cross-resistance to BRAF and MEK inhibitors by co-targeting the AKT/mTOR pathway.

Atefi M, von Euw E, Attar N, Ng C, Chu C, Guo D, Nazarian R, Chmielowski B, Glaspy JA, Comin-Anduix B, Mischel PS, Lo RS, Ribas A.

PLoS One. 2011;6(12):e28973. doi: 10.1371/journal.pone.0028973. Epub 2011 Dec 14.

31.

An old issue and a new look: electromagnetic hypersensitivity caused by radiations emitted by GSM mobile phones.

Mortazavi SM, Mahbudi A, Atefi M, Bagheri Sh, Bahaedini N, Besharati A.

Technol Health Care. 2011;19(6):435-43. doi: 10.3233/THC-2011-0641.

PMID:
22129944
32.

RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E).

Poulikakos PI, Persaud Y, Janakiraman M, Kong X, Ng C, Moriceau G, Shi H, Atefi M, Titz B, Gabay MT, Salton M, Dahlman KB, Tadi M, Wargo JA, Flaherty KT, Kelley MC, Misteli T, Chapman PB, Sosman JA, Graeber TG, Ribas A, Lo RS, Rosen N, Solit DB.

Nature. 2011 Nov 23;480(7377):387-90. doi: 10.1038/nature10662.

34.

PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro.

Finn RS, Dering J, Conklin D, Kalous O, Cohen DJ, Desai AJ, Ginther C, Atefi M, Chen I, Fowst C, Los G, Slamon DJ.

Breast Cancer Res. 2009;11(5):R77. doi: 10.1186/bcr2419.

Supplemental Content

Support Center